According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is -$1.16. In 2021 the company made an earnings per share (EPS) of $0.38.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$1.16 | -405.26% |
2021 | $0.38 | |
2019 | -$0.92 | -60.34% |
2018 | -$2.32 | |
2016 | $0.07000 | -96.2% |
2015 | $1.84 | -48.6% |
2014 | $3.58 | 138.67% |
2013 | $1.50 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $9.79 | -943.97% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $5.31 | -557.76% | ๐บ๐ธ USA |
![]() Sanofi SNY | $3.30 | -384.24% | ๐ซ๐ท France |
![]() Merck MRK | $6.03 | -619.83% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $0.66 | -156.90% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $8.30 | -815.50% | ๐ฌ๐ง UK |
![]() Dr. Reddy's RDY | $2.38 | -304.82% | ๐ฎ๐ณ India |